🔎 Trials Near Me

Home › Lymphoma › Arizona › Phoenix

Lymphoma clinical trials in Phoenix, AZ

7 studies for Lymphoma are looking for participants at sites in and around Phoenix (within about 30 miles). Open a study to see who can join and how to contact the study team.

A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)

RecruitingPhase 2
  • Banner MD Anderson Cancer Center, Phoenix
Ages 18 and older · All sexes · Updated Sep 17, 2026 · NCT07221500

CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma

RecruitingPhase 1/2
  • Phoenix Childrens Hospital, Phoenix
12 Months – 21 Years · All sexes · Updated Sep 11, 2026 · NCT04870944

Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML

RecruitingPhase 1/2
  • Mayo Clinic, Phoenix
Ages 12 and older · All sexes · Updated Sep 3, 2026 · NCT04588922

DALY II USA/ MB-CART2019.1 for DLBCL

RecruitingPhase 2
  • Mayo Clinic, Phoenix
Ages 18 and older · All sexes · Updated Jul 13, 2026 · NCT04792489

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

RecruitingObservational study
  • Phoenix Childrens Hospital, Phoenix
All ages · All sexes · Updated May 18, 2026 · NCT01790152

CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

RecruitingPhase 1/2
  • St. Joseph's Hospital and Medical Center, Phoenix
Ages 18 and older · All sexes · Updated Apr 16, 2026 · NCT03328078

About Lymphoma

Lymphoma is a cancer affecting the immune system. Hodgkins Lymphoma and Non Hodgkins Lymphoma are types of lymphoma. Learn about symptoms and treatments.

More about Lymphoma on MedlinePlus

Lymphoma trials in other cities

Other studies in Phoenix

From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.